Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

In this case study, Dr. Papasavva describes her laboratory’s journey from traditional thalassemia testing to state-of-the-art NGS technology and what a difference this has made in their daily work.

Instead of running on average three tests per
patient, they now only run one and get a
comprehensive analysis
The workflow is fast and simple; with just one
tube we can test most of the thalassemias
almost 100%
They can save on average 4 weeks for a patient
waiting for their diagnosis

Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

Get access to the case study by filling out the form below

Have you future-proofed
your cystic fibrosis testing?

Related content

Devyser CFTR 68 provides NHS Scotland with trustworthy, rapid results

Devyser achieves breakthrough in the US with cystic fibrosis NGS test

The utility of broader CFTR genotyping in cystic fibrosis populations

Revised guidelines for cystic fibrosis carrier screening: The American College of Medical Genetics and Genomics (ACMG) expands CFTR screening recommendations

Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

Get access to the case study by filling out the form below

Have you future-proofedyour cystic fibrosis testing?

Related content

Devyser CFTR 68 provides NHS Scotland with trustworthy, rapid results

Devyser achieves breakthrough in the US with cystic fibrosis NGS test

The utility of broader CFTR genotyping in cystic fibrosis populations

Revised guidelines for cystic fibrosis carrier screening: The American College of Medical Genetics and Genomics (ACMG) expands CFTR screening recommendations

Have you future-proofed
your cystic fibrosis testing?